Most LIHC patients in the TCGA-LIHC database are categorized as presenting with existing C3 and C4 immune subtypes, whereas existing C5 immune subtype was not detected in any sample in the HCC TCGA dataset. This evidence concerns the gene C3 and hepatocellular carcinoma.